High Dose, Highly Purified Beta Glucan
Glucan Expand Radiation Research
DC – November 19, 2002 – The Henry M. Jackson Foundation for the
Advancement of Military Medicine, Inc. have entered into a joint
research agreement with the Armed Forces Radiobiology Research
Institute (AFRRI) to determine the radio protective benefits of
Transfer Point patented beta 1,3 glucans and to work together toward
the anticipated implementation of the research.
exposure destroys the bone marrow and depletes the white blood cells
that defend against infection and disease. In preclinical research,
AFRRI has demonstrated that systemic yeast beta 1,3 glucans enhanced
mouse resistance to sub-lethal and lethal doses of radiation. Beta
glucan stimulated bone marrow recovery of white blood cells and
increased their infection-fighting activity.
the new research agreement, AFRRI will conduct a series of
studies over the next 180 days to determine the safety and efficacy
of orally administered WGP Beta Glucan to protect animals against
radiation and infectious disease. If this preclinical research is
successful, the joint team will execute a plan to develop WGP Beta
Glucan formulations that can be used in state and federal programs
designed to protect U.S. government employees, military personnel
and citizens from national disasters.
Henry M. Jackson Foundation for the Advancement of Military
Medicine, Inc. is a private, not-for-profit organization chartered
by Congress to support military medical research and education at
the Uniformed Services University of the Health Sciences and
throughout military medicine. Website: www.hjf.org.
Armed Forces Radiobiology Research Institute, Uniformed Services
University of the Health Sciences, is a triservice research
laboratory chartered in 1961 whose focus is developing potential
products in the field of radiobiology and related matters essential
to the operational and medical support of the U.S. Department of
Defense and the military services. AFRRI’s mission is to develop
products that may protect military personnel against
radiation-induced immunosuppression and infectious disease. Website:
Point and it partners is a leading biotechnology company in the
field of natural complex carbohydrates or biopolymers. The company
is developing carbohydrate-based products for a wide range of
therapeutic, consumer and industrial applications.